162 related articles for article (PubMed ID: 34700224)
1. White adipocyte-targeted dual gene silencing of FABP4/5 for anti-obesity, anti-inflammation and reversal of insulin resistance: Efficacy and comparison of administration routes.
Chung JY; Hong J; Kim HJ; Song Y; Yong SB; Lee J; Kim YH
Biomaterials; 2021 Dec; 279():121209. PubMed ID: 34700224
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of CRISPR interference system against
Chung JY; Ain QU; Song Y; Yong SB; Kim YH
Genome Res; 2019 Sep; 29(9):1442-1452. PubMed ID: 31467027
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice.
Yang R; Castriota G; Chen Y; Cleary MA; Ellsworth K; Shin MK; Tran JL; Vogt TF; Wu M; Xu S; Yang X; Zhang BB; Berger JP; Qureshi SA
Int J Obes (Lond); 2011 Feb; 35(2):217-25. PubMed ID: 20603627
[TBL] [Abstract][Full Text] [Related]
4. Oligopeptide complex for targeted non-viral gene delivery to adipocytes.
Won YW; Adhikary PP; Lim KS; Kim HJ; Kim JK; Kim YH
Nat Mater; 2014 Dec; 13(12):1157-64. PubMed ID: 25282508
[TBL] [Abstract][Full Text] [Related]
5. Fabp4-Cre-mediated
Xiong X; Zhang C; Zhang Y; Fan R; Qian X; Dong XC
J Endocrinol; 2017 Jun; 233(3):307-314. PubMed ID: 28385723
[TBL] [Abstract][Full Text] [Related]
6. The cytoskeletal protein septin 11 is associated with human obesity and is involved in adipocyte lipid storage and metabolism.
Moreno-Castellanos N; Rodríguez A; Rabanal-Ruiz Y; Fernández-Vega A; López-Miranda J; Vázquez-Martínez R; Frühbeck G; Malagón MM
Diabetologia; 2017 Feb; 60(2):324-335. PubMed ID: 27866222
[TBL] [Abstract][Full Text] [Related]
7. Associations between Fatty Acid-Binding Protein 4⁻A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus.
Trojnar M; Patro-Małysza J; Kimber-Trojnar Ż; Leszczyńska-Gorzelak B; Mosiewicz J
Cells; 2019 Mar; 8(3):. PubMed ID: 30857223
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem Cells.
Yamamoto T; Furuhashi M; Sugaya T; Oikawa T; Matsumoto M; Funahashi Y; Matsukawa Y; Gotoh M; Miura T
PLoS One; 2016; 11(12):e0167825. PubMed ID: 27936164
[TBL] [Abstract][Full Text] [Related]
9. Visceral adipose tissue macrophage-targeted TACE silencing to treat obesity-induced type 2 diabetes.
Yong SB; Song Y; Kim YH
Biomaterials; 2017 Dec; 148():81-89. PubMed ID: 28985514
[TBL] [Abstract][Full Text] [Related]
10. Unconventional Secretion of Adipocyte Fatty Acid Binding Protein 4 Is Mediated By Autophagic Proteins in a Sirtuin-1-Dependent Manner.
Josephrajan A; Hertzel AV; Bohm EK; McBurney MW; Imai SI; Mashek DG; Kim DH; Bernlohr DA
Diabetes; 2019 Sep; 68(9):1767-1777. PubMed ID: 31171562
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity.
Lan H; Cheng CC; Kowalski TJ; Pang L; Shan L; Chuang CC; Jackson J; Rojas-Triana A; Bober L; Liu L; Voigt J; Orth P; Yang X; Shipps GW; Hedrick JA
J Lipid Res; 2011 Apr; 52(4):646-56. PubMed ID: 21296956
[TBL] [Abstract][Full Text] [Related]
12. Gene Expression and Correlation of Pten and Fabp4 in Liver, Muscle, and Adipose Tissues of Type 2 Diabetes Rats.
Su D; Zhang CL; Gao YC; Liu XY; Li CP; Huangfu J; Xiao R
Med Sci Monit; 2015 Nov; 21():3616-21. PubMed ID: 26591002
[TBL] [Abstract][Full Text] [Related]
13. Adipose-specific Vdr deletion alters body fat and enhances mammary epithelial density.
Matthews DG; D'Angelo J; Drelich J; Welsh J
J Steroid Biochem Mol Biol; 2016 Nov; 164():299-308. PubMed ID: 26429395
[TBL] [Abstract][Full Text] [Related]
14. FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels.
Queipo-Ortuño MI; Escoté X; Ceperuelo-Mallafré V; Garrido-Sanchez L; Miranda M; Clemente-Postigo M; Pérez-Pérez R; Peral B; Cardona F; Fernández-Real JM; Tinahones FJ; Vendrell J
PLoS One; 2012; 7(11):e48605. PubMed ID: 23139800
[TBL] [Abstract][Full Text] [Related]
15. LMO3 reprograms visceral adipocyte metabolism during obesity.
Wagner G; Fenzl A; Lindroos-Christensen J; Einwallner E; Husa J; Witzeneder N; Rauscher S; Gröger M; Derdak S; Mohr T; Sutterlüty H; Klinglmüller F; Wolkerstorfer S; Fondi M; Hoermann G; Cao L; Wagner O; Kiefer FW; Esterbauer H; Bilban M
J Mol Med (Berl); 2021 Aug; 99(8):1151-1171. PubMed ID: 34018016
[TBL] [Abstract][Full Text] [Related]
16. Lack of Gα
Leiss V; Schönsiegel A; Gnad T; Kerner J; Kaur J; Sartorius T; Machann J; Schick F; Birnbaumer L; Häring HU; Pfeifer A; Nürnberg B
Mol Metab; 2020 Oct; 40():101029. PubMed ID: 32480042
[TBL] [Abstract][Full Text] [Related]
17. A New Insight into Fatty Acid Binding Protein 4 Mechanisms and Therapeutic Implications in Obesity-Associated Diseases: A Mini Review.
Başarır Sivri FN; Çiftçi S
Mol Nutr Food Res; 2024 Apr; 68(8):e2300840. PubMed ID: 38593305
[TBL] [Abstract][Full Text] [Related]
18. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
Furuhashi M
J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
[TBL] [Abstract][Full Text] [Related]
19. Regulative effect of maternal serum fatty acid-binding protein 4 on insulin resistance and the development of gestational diabetes mellitus.
Duan B; Li Y; Dong K; Sun Y; Ma A; Yang X
Prostaglandins Leukot Essent Fatty Acids; 2020 Dec; 163():102213. PubMed ID: 33260074
[TBL] [Abstract][Full Text] [Related]
20. Identification of new dual FABP4/5 inhibitors based on a naphthalene-1-sulfonamide FABP4 inhibitor.
He Y; Dou H; Gao D; Wang T; Zhang M; Wang H; Li Y
Bioorg Med Chem; 2019 Oct; 27(19):115015. PubMed ID: 31420256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
